Grifols Partnership is a business-to-business contract development and manufacturing platform for sterile solutions and lipid emulsions with over 75 years’ experience in producing intravenous solutions for the pharmaceutical industry worldwide.
Grifols Partnership is a business-to-business contract development and manufacturing platform for sterile solutions and lipid emulsions with a long-term experience in producing intravenous solutions for the pharmaceutical industry worldwide.
Over the years we have established successful relationships with customers in global markets, including North America, Canada, Australia and Europe in the following areas:
• Human & Veterinary fields
• New product development
• Validation batches
• Generic drug development and manufacturing
Grifols Partnership has two FDA and GMP approved manufacturing facilities in Spain for intravenous solutions that have parametric release certification.
We specialize in small molecule intravenous solutions and offer high quality pharmaceutical development and product manufacturing. Our portfolio also includes products which require careful design and assembly including medical devices and bags for blood storage and collection.
• Drug Product Development
• Small Molecule Drug Products
• Terminal Sterilization
• Light and O2 sensitive products
• Emulsion Technology
• Vials (5 to 50 mL)
• Glass Bottles (50 to 500 mL)
• Flexible Containers (PP bags, 50 to 1000 mL)
• FFS technology for PP bags
• Regulatory Approvals
Company name: Grifols International S.A
Stand/Booth number: Hall 12.1, Booth 121C70
Related Content:Sponsored Resources